• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白胆固醇水平低的患者中高密度脂蛋白胆固醇的临床意义

Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.

作者信息

deGoma Emil M, Leeper Nicholas J, Heidenreich Paul A

机构信息

Department of Cardiology, Stanford University Hospital, Stanford, California 94305, USA.

出版信息

J Am Coll Cardiol. 2008 Jan 1;51(1):49-55. doi: 10.1016/j.jacc.2007.07.086.

DOI:10.1016/j.jacc.2007.07.086
PMID:18174036
Abstract

OBJECTIVES

We sought to evaluate the significance of high-density lipoprotein cholesterol (HDL-C) in the context of low low-density lipoprotein cholesterol (LDL-C).

BACKGROUND

Earlier studies support an inverse correlation between circulating HDL-C and coronary risk in patients with normal or elevated LDL-C.

METHODS

This study involved 4,188 patients attending the Palo Alto Veterans Administration Medical Center or affiliated clinics with LDL-C levels below 60 mg/dl. Outcomes were examined 1 year after the index LDL-C date. The combined primary end point was myocardial injury or hospitalization from ischemic heart disease. The secondary end point was all-cause mortality.

RESULTS

Mean HDL-C levels (mg/dl) by quartile (Q) were: Q1 28 mg/dl, Q2 36 mg/dl, Q3 43 mg/dl, and Q4 63 mg/dl. The rate of myocardial injury or hospitalization for ischemic heart disease showed an inverse relationship to HDL-C (adjusted odds ratios: Q1 1.59 [95% confidence interval (CI) 1.16 to 2.19], Q2 1.39 [95% CI 1.01 to 1.92], Q3 1.33 [95% CI 0.96 to 1.84], and Q4 reference) that persisted regardless of statin use or recent myocardial injury. Analyzing HDL-C as a continuous variable revealed a 10% [95% CI 3% to 17%] increase in the combined end point of myocardial injury or hospitalization for ischemic heart disease for every 10-mg/dl decrease in HDL-C. The unadjusted and adjusted incidence of all-cause mortality demonstrated a U-shaped relationship to HDL-C (adjusted odds ratios: Q1 1.13 [95% CI 0.79 to 1.62], Q2 0.97 [95% CI 0.67 to 1.40], Q3 0.74 [95% CI 0.50 to 1.09], and Q4 reference).

CONCLUSIONS

The inverse relationship between HDL-C and coronary risk persists even among patients with LDL-C below 60 mg/dl, although a U-shaped relationship is observed between HDL-C and all-cause mortality.

摘要

目的

我们试图评估在低密度脂蛋白胆固醇(LDL-C)水平较低的情况下高密度脂蛋白胆固醇(HDL-C)的意义。

背景

早期研究支持在LDL-C正常或升高的患者中,循环HDL-C与冠心病风险呈负相关。

方法

本研究纳入了4188名就诊于帕洛阿尔托退伍军人管理局医疗中心或附属诊所且LDL-C水平低于60mg/dl的患者。在LDL-C指标日期后1年对结局进行检查。联合主要终点为心肌损伤或因缺血性心脏病住院。次要终点为全因死亡率。

结果

按四分位数(Q)划分的平均HDL-C水平(mg/dl)分别为:Q1 28mg/dl,Q2 36mg/dl,Q3 43mg/dl,Q4 63mg/dl。心肌损伤或因缺血性心脏病住院的发生率与HDL-C呈负相关(校正比值比:Q1 1.59 [95%置信区间(CI)1.16至2.19],Q2 1.39 [95%CI 1.01至1.92],Q3 1.33 [95%CI 0.96至1.84],Q4为参照),无论是否使用他汀类药物或近期有无心肌损伤,这种相关性均持续存在。将HDL-C作为连续变量分析显示,HDL-C每降低10mg/dl,心肌损伤或因缺血性心脏病住院的联合终点增加10%[95%CI 3%至17%]。全因死亡率的未校正和校正发生率与HDL-C呈U形关系(校正比值比:Q1 1.13 [95%CI 0.79至1.62],Q2 0.97 [95%CI 0.67至1.40],Q3 0.74 [95%CI 0.50至1.09],Q4为参照)。

结论

即使在LDL-C低于60mg/dl的患者中,HDL-C与冠心病风险之间的负相关关系依然存在,尽管HDL-C与全因死亡率之间呈U形关系。

相似文献

1
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.低密度脂蛋白胆固醇水平低的患者中高密度脂蛋白胆固醇的临床意义
J Am Coll Cardiol. 2008 Jan 1;51(1):49-55. doi: 10.1016/j.jacc.2007.07.086.
2
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.普伐他汀对2073例低密度脂蛋白胆固醇和高密度脂蛋白胆固醇水平均较低患者冠状动脉事件的影响:LIPID研究结果
Eur Heart J. 2004 May;25(9):771-7. doi: 10.1016/j.ehj.2004.03.013.
3
Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).提高高密度脂蛋白胆固醇水平及降低低密度脂蛋白胆固醇水平对首次急性冠脉事件发生率的影响(来自空军/德州冠状动脉粥样硬化预防研究)
Am J Cardiol. 2009 Sep 15;104(6):829-34. doi: 10.1016/j.amjcard.2009.05.020.
4
Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.已确诊冠心病或风险等同情况且低密度脂蛋白胆固醇得到控制的患者中低高密度脂蛋白胆固醇的患病率。
Am J Cardiol. 2007 Nov 15;100(10):1499-501. doi: 10.1016/j.amjcard.2007.06.058. Epub 2007 Sep 27.
5
Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl.低密度脂蛋白<70mg/dl的患者经皮冠状动脉介入治疗后高密度脂蛋白胆固醇与死亡率的关系。
Am J Cardiol. 2009 Feb 1;103(3):350-4. doi: 10.1016/j.amjcard.2008.09.087. Epub 2008 Nov 19.
6
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.基线低密度脂蛋白胆固醇是强化降脂治疗获益的重要预测指标:PROVE IT-TIMI 22(普伐他汀或阿托伐他汀评估与感染治疗-心肌梗死溶栓22)分析。
J Am Coll Cardiol. 2008 Sep 9;52(11):914-20. doi: 10.1016/j.jacc.2008.05.046.
7
Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.脂质治疗评估项目2:一项评估实现低密度脂蛋白胆固醇目标的患者比例的跨国调查。
Circulation. 2009 Jul 7;120(1):28-34. doi: 10.1161/CIRCULATIONAHA.108.838466. Epub 2009 Jun 22.
8
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).冠心病患者中提高高密度脂蛋白胆固醇的临床获益与血清低密度脂蛋白胆固醇水平的关系(来自苯扎贝特预防心肌梗死试验)
Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.
9
The influence of statin medications on prostate-specific antigen levels.他汀类药物对前列腺特异性抗原水平的影响。
J Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi: 10.1093/jnci/djn362. Epub 2008 Oct 28.
10
Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.在降脂治疗的随机对照试验中,基线和治疗中的高密度脂蛋白胆固醇与癌症风险。
J Am Coll Cardiol. 2010 Jun 22;55(25):2846-54. doi: 10.1016/j.jacc.2009.12.069.

引用本文的文献

1
Clinical value of Lp-PLA2, LDL-C, HDL-C, hs-CRP, leukocyte, FPG and HbA1c in type 2 diabetes mellitus patients with acute ischemic stroke.Lp-PLA2、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、超敏C反应蛋白(hs-CRP)、白细胞、空腹血糖(FPG)及糖化血红蛋白(HbA1c)在2型糖尿病合并急性缺血性脑卒中患者中的临床价值
Front Endocrinol (Lausanne). 2025 Apr 17;16:1546961. doi: 10.3389/fendo.2025.1546961. eCollection 2025.
2
Detailed Lipid Profiles and Lipid-related Residual Risk after 12-week 10 mg Rosuvastatin Treatment for Acute Myocardial Infarction.急性心肌梗死患者经 10 毫克瑞舒伐他汀治疗 12 周后的详细血脂谱和血脂相关残余风险。
Intern Med. 2024 Nov 15;63(22):3031-3038. doi: 10.2169/internalmedicine.3476-24. Epub 2024 Mar 18.
3
The prognostic impact of HDL-C level in patients presenting with ST-elevation myocardial infarction.
高密度脂蛋白胆固醇(HDL-C)水平对ST段抬高型心肌梗死患者预后的影响。
Br J Cardiol. 2023 Jan 18;30(1):5. doi: 10.5837/bjc.2023.005. eCollection 2023.
4
HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS.在 LDL 血浆水平达标的且首次发生急性冠脉综合征的患者中,高密度脂蛋白的功能和大小。
Int J Mol Sci. 2023 Mar 11;24(6):5391. doi: 10.3390/ijms24065391.
5
The Role of High-Density Lipoprotein Cholesterol in 2022.2022 年高密度脂蛋白胆固醇的作用。
Curr Atheroscler Rep. 2022 May;24(5):365-377. doi: 10.1007/s11883-022-01012-y. Epub 2022 Mar 10.
6
Prevalence of Dyslipidemia in Tibetan Monks from Gansu Province, Northwest China.中国西北甘肃省藏族僧侣血脂异常患病率
Open Life Sci. 2020 May 7;15:152-158. doi: 10.1515/biol-2020-0016. eCollection 2020.
7
High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.他汀类药物治疗稳定型冠状动脉疾病患者的高密度脂蛋白胆固醇与心血管事件:REAL-CAD 研究观察结果。
J Atheroscler Thromb. 2022 Jan 1;29(1):50-68. doi: 10.5551/jat.59881. Epub 2021 Jan 9.
8
The U Shaped Relationship Between High-Density Lipoprotein Cholesterol and All-Cause or Cause-Specific Mortality in Adult Population.高密度脂蛋白胆固醇与成人全因或死因特异性死亡率之间的 U 型关系。
Clin Interv Aging. 2020 Oct 2;15:1883-1896. doi: 10.2147/CIA.S271528. eCollection 2020.
9
The Relationship Between Premature Myocardial Infarction with TC/HDL-C Ratio Subgroups in a Multiple Risk Factor Model.多危险因素模型中早发心肌梗死与TC/HDL-C比值亚组的关系
Adv J Emerg Med. 2019 May 12;3(3):e24. doi: 10.22114/ajem.v0i0.149. eCollection 2019 Summer.
10
Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD.血清高密度脂蛋白胆固醇水平与慢性肾脏病进展的关系:来自 KNOW-CKD 的结果。
J Am Heart Assoc. 2019 Mar 19;8(6):e011162. doi: 10.1161/JAHA.118.011162.